Description

Rubifen (Methylphenidate Hydrochloride) – CNS Stimulant for ADHD (Rx)

Rubifen (methylphenidate hydrochloride) is a central nervous system (CNS) stimulant indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children (≥6 years), adolescents, and adults (depending on regional approval). It is used as part of a comprehensive treatment program that includes psychological, educational, and behavioral interventions.

Methylphenidate works by inhibiting the reuptake of dopamine and norepinephrine in the brain, increasing their availability in synaptic clefts. This enhances activity in the prefrontal cortex, improving attention, concentration, and impulse control while reducing hyperactivity.

buy Rubifen without prescription

We sell over-the-counter Rubifen medicine;
livraison rapide, discrète et fiable
Paiement rapide et sécurisé
faire des achats en toute discrétion sans laisser de traces

Détails clés

• Active Ingredient: Methylphenidate hydrochloride
• Drug Class: CNS stimulant (psychostimulant)
• Indication: ADHD
• Mechanism of Action: Dopamine and norepinephrine reuptake inhibition
• Therapeutic Effects: Improved attention, reduced impulsivity, behavioral stabilization
• Prescription Status: Controlled prescription medicine

Cahier des charges

• Dosage Forms: Immediate-release tablets
• Common Strengths: 5 mg, 10 mg, 20 mg
• Administration : Orale
• Onset of Action: ~20–60 minutes
• Peak Effect: ~1–3 hours
• Duration of Action: ~3–4 hours
• Half-Life: ~2–3 hours
• Bioavailability: ~30% (first-pass metabolism)
• Métabolisme : Hépatique
• Excrétion : rénale
• Conservation : température ambiante

Dosage et administration

• Initial dose: Low starting dose with gradual titration
• Typically taken 2–3 times daily (morning and early afternoon)
• Should be taken before meals
• Maximum daily dose varies depending on patient profile and guidelines
• Requires specialist supervision

Compatibilité / Utilisation appropriée

• Children (≥6 years), adolescents, and adults with ADHD
• Patients requiring short-acting stimulant therapy
• Suitable for flexible dosing schedules
• Used alongside behavioral and psychological interventions
• Requires medical monitoring

Contre-indications

• Severe cardiovascular disorders
• Hyperthyroïdie
• Glaucome
• Severe psychiatric conditions (e.g., psychosis)
• Use with monoamine oxidase inhibitors (MAOIs)

Why Choose Rubifen?

Rubifen provides effective short-acting methylphenidate therapy for ADHD, allowing precise dose timing and control throughout the day. It is a well-established option in structured ADHD treatment programs when supervised by a healthcare professional.